ESR1 and breast carcinoma: ErbB2-positive and ER-positive breast cancers have been shown to exhibit significantly different gene expression profiles[26], however, gene expression studies to date have failed to discriminate ErbB2-positive/ER-positive breast cancers from either ErbB2-positive or ER-positive subgroups.